Ready for your next step ?
About us
Magle Group is aiming to be leading in high-quality life-changing healthcare innovations, meeting medical needs through scientific excellence.
Our Group includes four operative companies with excellent success records operating under the Magle Group banner: Magle Biopharma, Magle Biopolymers, Magle Chemoswed and Magle PharmaCept.
Magle Chemoswed is a Contract Manufaturing and Development Organization (CDMO) and serve companies in the pharmaceutical and medical device industry, providing comprehensive services from development through manufacturing on a contract basis. Together with our partners, they take innovations from idea to product.
Magle PharmaCept is a company that markets a range of high-quality innovative products within tumor diseases and surgical areas, based on their own Degradable Starch Microspheres (DSM) technology platform. Their products are registered and approved as medical devices in a number of therapeutic areas, showing high efficacy and good tolerability.
We at Magle
Magle is a unique company consisting of unique people. What we have in common is the devotion to having a positive impact on the health of people around the world.
At Magle we see everyone's work as equally valuable and important. Together we work towards our shared vision, guided by the same company values. We know from experience that when we are working together as one, we accomplish great things.
Meet some of the Magle team!
Together we commit to making an IMPACT
IMPACT guides us in reaching our winning aspiration – to bring high quality life changing healthcare innovations to patients in need
IMPACT defines who we are as a company, what we stand for, and how we behave – towards each other, customers, and business partners
About Magle Group
Magle AB (formed in 1995 as a pure development company) acquired Chemoswed AB (formed in 1944 as a manufacturing company) in 2016 before merging the companies in 2017 to form Magle Chemoswed. In 2019, Adroit Science AB was acquired to increase the development services segment. In 2021, PharmaCept GmbH was acquired as a first step to develop a sales and marketing organization for DSM products. Most recent to join the Magle Group is Magle Biopolymers - a CDMO part of the group focusing on Dextran technology.
Already working at Magle Group?
Let’s recruit together and find your next colleague.